Brekiya® is now available for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

Dr. Carrie Jose, in her latest Health and Wellness column, provides five ways to tell if your neck is the hidden cause of ...

Ltd on Monday said it has received final approval from the US health regulator for its generic version of Sumatriptan injection used in treatment of migraine.   The approval by the US Food & Drug ...

Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration ...

Brekiya ® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling Specialty Pharmacy BRIDGEWATER, N.J., Oct.

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 ...

Amneal Pharmaceuticals’ price target remains steady at $13.50, reflecting ongoing confidence in its consensus valuation despite recent market shifts. Analysts’ latest revisions stem from upbeat ...

Alembic Pharma receives US FDA final approval for sumatriptan injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, single-dose autoinjector system: Our Bureau, Mumbai Monday, November 10, ...

After 20 years in the Air Force, I’ve seen the invisible wounds of war up close and personal. I’ve watched brothers and ...

Alembic Pharmaceuticals received USFDA approval for its Sumatriptan injection, a generic equivalent for treating migraines and cluster headaches. This marks Alembic's first drug device combination.

The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.